HEADER IMMUNE SYSTEM 09-APR-20 6WIB TITLE NEXT GENERATION MONOMERIC IGG4 FC COMPND MOL_ID: 1; COMPND 2 MOLECULE: IMMUNOGLOBULIN HEAVY CONSTANT GAMMA 4; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: IG GAMMA-4 CHAIN C REGION; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IGHG4; SOURCE 6 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10029 KEYWDS ANTIBODY CONSTANT REGION, FRAGMENT CRYSTALLIZABLE, MUTATED, IMMUNE KEYWDS 2 SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR V.Y.OGANESYAN,L.SHAN,W.DALL'ACQUA,N.VAN DYK REVDAT 3 18-OCT-23 6WIB 1 REMARK REVDAT 2 22-SEP-21 6WIB 1 JRNL REVDAT 1 15-SEP-21 6WIB 0 JRNL AUTH L.SHAN,N.V.DYK,N.HASKINS,K.M.COOK,K.L.ROSENTHAL,R.MAZOR, JRNL AUTH 2 S.DRAGULIN-OTTO,Y.JIANG,H.WU,W.F.DALL'ACQUA,M.J.BORROK, JRNL AUTH 3 M.M.DAMSCHRODER,V.OGANESYAN JRNL TITL IN VIVO PHARMACOKINETIC ENHANCEMENT OF MONOMERIC FC AND JRNL TITL 2 MONOVALENT BISPECIFIC DESIGNS THROUGH STRUCTURAL GUIDANCE. JRNL REF COMMUN BIOL V. 4 1048 2021 JRNL REFN ESSN 2399-3642 JRNL PMID 34497355 JRNL DOI 10.1038/S42003-021-02565-5 REMARK 2 REMARK 2 RESOLUTION. 2.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.92 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 11380 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.219 REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 612 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.55 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.61 REMARK 3 REFLECTION IN BIN (WORKING SET) : 824 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.3220 REMARK 3 BIN FREE R VALUE SET COUNT : 40 REMARK 3 BIN FREE R VALUE : 0.2700 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1674 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 101 REMARK 3 SOLVENT ATOMS : 14 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.64 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.71000 REMARK 3 B22 (A**2) : -2.98000 REMARK 3 B33 (A**2) : -2.73000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.366 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.273 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.206 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.813 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.926 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.894 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1825 ; 0.009 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 1628 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2494 ; 1.739 ; 1.734 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3837 ; 1.197 ; 1.645 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 209 ; 8.059 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 85 ;36.558 ;23.529 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 301 ;18.881 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 8 ;23.577 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 255 ; 0.069 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1921 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 344 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6WIB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-APR-20. REMARK 100 THE DEPOSITION ID IS D_1000248239. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-AUG-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.19499 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : POINTLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11992 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.550 REMARK 200 RESOLUTION RANGE LOW (A) : 35.920 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.300 REMARK 200 R MERGE (I) : 0.15400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.66 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.95800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 5HVW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.73 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.01 M ZINC SULFATE HEPTAHYDRATE; 0.1 REMARK 280 M MORPHOLINEETHANESULFONIC ACID (MES) MONOHYDRATE, PH 6.5, AND REMARK 280 25% (W/V) PEG 550 MME AT A PROTEIN CONCENTRATION OF 5.5 MG/ML, REMARK 280 VAPOR DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 34.52200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 34.52200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 50.65300 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 50.86550 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 50.65300 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 50.86550 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 34.52200 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 50.65300 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 50.86550 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 34.52200 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 50.65300 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 50.86550 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH1 ARG A 409 OG1 THR A 411 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 270 74.29 -112.17 REMARK 500 ASN A 297 30.95 -86.67 REMARK 500 LYS A 317 152.58 -48.39 REMARK 500 PRO A 374 -168.69 -79.57 REMARK 500 ASN A 384 64.31 37.97 REMARK 500 SER A 400 -35.80 -36.32 REMARK 500 GLU A 419 -9.46 -57.31 REMARK 500 TRP A 434 14.83 56.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 NAG B 5 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 503 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 272 OE2 REMARK 620 2 GLU A 345 OE2 22.4 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 501 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 285 NE2 REMARK 620 2 HOH A 604 O 68.7 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 502 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 294 OE1 REMARK 620 2 GLU A 294 OE2 57.1 REMARK 620 3 HIS A 310 NE2 8.9 64.6 REMARK 620 4 HIS A 435 NE2 7.5 61.6 3.3 REMARK 620 5 HOH A 601 O 10.2 65.5 1.4 3.9 REMARK 620 N 1 2 3 4 DBREF 6WIB A 235 444 UNP P01861 IGHG4_HUMAN 115 325 SEQADV 6WIB PHE A 351 UNP P01861 LEU 231 ENGINEERED MUTATION SEQADV 6WIB ARG A 366 UNP P01861 THR 246 ENGINEERED MUTATION SEQADV 6WIB LYS A 395 UNP P01861 PRO 275 ENGINEERED MUTATION SEQADV 6WIB ARG A 405 UNP P01861 PHE 285 ENGINEERED MUTATION SEQADV 6WIB GLU A 407 UNP P01861 TYR 287 ENGINEERED MUTATION SEQADV 6WIB CYS A 432 UNP P01861 LEU 312 ENGINEERED MUTATION SEQADV 6WIB SER A 433 UNP P01861 HIS 313 ENGINEERED MUTATION SEQADV 6WIB TRP A 434 UNP P01861 ASN 314 ENGINEERED MUTATION SEQADV 6WIB LEU A 436 UNP P01861 TYR 316 ENGINEERED MUTATION SEQADV 6WIB CYS A 437 UNP P01861 THR 317 ENGINEERED MUTATION SEQADV 6WIB A UNP P01861 GLN 318 DELETION SEQRES 1 A 210 LEU GLY GLY PRO SER VAL PHE LEU PHE PRO PRO LYS PRO SEQRES 2 A 210 LYS ASP THR LEU MET ILE SER ARG THR PRO GLU VAL THR SEQRES 3 A 210 CYS VAL VAL VAL ASP VAL SER GLN GLU ASP PRO GLU VAL SEQRES 4 A 210 GLN PHE ASN TRP TYR VAL ASP GLY VAL GLU VAL HIS ASN SEQRES 5 A 210 ALA LYS THR LYS PRO ARG GLU GLU GLN PHE ASN SER THR SEQRES 6 A 210 TYR ARG VAL VAL SER VAL LEU THR VAL LEU HIS GLN ASP SEQRES 7 A 210 TRP LEU ASN GLY LYS GLU TYR LYS CYS LYS VAL SER ASN SEQRES 8 A 210 LYS GLY LEU PRO SER SER ILE GLU LYS THR ILE SER LYS SEQRES 9 A 210 ALA LYS GLY GLN PRO ARG GLU PRO GLN VAL TYR THR PHE SEQRES 10 A 210 PRO PRO SER GLN GLU GLU MET THR LYS ASN GLN VAL SER SEQRES 11 A 210 LEU ARG CYS LEU VAL LYS GLY PHE TYR PRO SER ASP ILE SEQRES 12 A 210 ALA VAL GLU TRP GLU SER ASN GLY GLN PRO GLU ASN ASN SEQRES 13 A 210 TYR LYS THR THR LYS PRO VAL LEU ASP SER ASP GLY SER SEQRES 14 A 210 PHE ARG LEU GLU SER ARG LEU THR VAL ASP LYS SER ARG SEQRES 15 A 210 TRP GLN GLU GLY ASN VAL PHE SER CYS SER VAL MET HIS SEQRES 16 A 210 GLU ALA CYS SER TRP HIS LEU CYS LYS SER LEU SER LEU SEQRES 17 A 210 SER LEU HET NAG B 1 14 HET NAG B 2 14 HET BMA B 3 11 HET MAN B 4 11 HET NAG B 5 13 HET MAN B 6 11 HET NAG B 7 14 HET FUC B 8 10 HET ZN A 501 1 HET ZN A 502 1 HET ZN A 503 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM ZN ZINC ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 2 NAG 4(C8 H15 N O6) FORMUL 2 BMA C6 H12 O6 FORMUL 2 MAN 2(C6 H12 O6) FORMUL 2 FUC C6 H12 O5 FORMUL 3 ZN 3(ZN 2+) FORMUL 6 HOH *14(H2 O) HELIX 1 AA1 LYS A 246 MET A 252 1 7 HELIX 2 AA2 LEU A 309 ASN A 315 1 7 HELIX 3 AA3 GLU A 356 LYS A 360 5 5 HELIX 4 AA4 LYS A 414 GLU A 419 1 6 HELIX 5 AA5 CYS A 432 LEU A 436 5 5 SHEET 1 AA1 4 SER A 239 PHE A 243 0 SHEET 2 AA1 4 GLU A 258 VAL A 266 -1 O VAL A 262 N PHE A 241 SHEET 3 AA1 4 THR A 299 THR A 307 -1 O SER A 304 N CYS A 261 SHEET 4 AA1 4 LYS A 288 THR A 289 -1 N LYS A 288 O VAL A 305 SHEET 1 AA2 4 SER A 239 PHE A 243 0 SHEET 2 AA2 4 GLU A 258 VAL A 266 -1 O VAL A 262 N PHE A 241 SHEET 3 AA2 4 THR A 299 THR A 307 -1 O SER A 304 N CYS A 261 SHEET 4 AA2 4 GLU A 293 GLN A 295 -1 N GLN A 295 O THR A 299 SHEET 1 AA3 4 VAL A 282 VAL A 284 0 SHEET 2 AA3 4 GLN A 274 VAL A 279 -1 N VAL A 279 O VAL A 282 SHEET 3 AA3 4 TYR A 319 SER A 324 -1 O LYS A 322 N ASN A 276 SHEET 4 AA3 4 ILE A 332 ILE A 336 -1 O ILE A 332 N VAL A 323 SHEET 1 AA4 4 GLN A 347 PHE A 351 0 SHEET 2 AA4 4 GLN A 362 PHE A 372 -1 O LEU A 368 N TYR A 349 SHEET 3 AA4 4 PHE A 404 ASP A 413 -1 O PHE A 404 N PHE A 372 SHEET 4 AA4 4 TYR A 391 THR A 393 -1 N LYS A 392 O ARG A 409 SHEET 1 AA5 4 GLN A 347 PHE A 351 0 SHEET 2 AA5 4 GLN A 362 PHE A 372 -1 O LEU A 368 N TYR A 349 SHEET 3 AA5 4 PHE A 404 ASP A 413 -1 O PHE A 404 N PHE A 372 SHEET 4 AA5 4 VAL A 397 LEU A 398 -1 N VAL A 397 O ARG A 405 SHEET 1 AA6 3 GLN A 386 GLU A 388 0 SHEET 2 AA6 3 ALA A 378 SER A 383 -1 N TRP A 381 O GLU A 388 SHEET 3 AA6 3 PHE A 423 MET A 428 -1 O SER A 426 N GLU A 380 SSBOND 1 CYS A 261 CYS A 321 1555 1555 2.00 SSBOND 2 CYS A 367 CYS A 425 1555 1555 2.07 SSBOND 3 CYS A 432 CYS A 437 1555 1555 2.03 LINK ND2 ASN A 297 C1 NAG B 1 1555 1555 1.44 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.43 LINK O6 NAG B 1 C1 FUC B 8 1555 1555 1.45 LINK O4 NAG B 2 C1 BMA B 3 1555 1555 1.41 LINK O3 BMA B 3 C1 MAN B 4 1555 1555 1.44 LINK O6 BMA B 3 C1 MAN B 6 1555 1555 1.43 LINK O2 MAN B 4 C1 NAG B 5 1555 1555 1.42 LINK O2 MAN B 6 C1 NAG B 7 1555 1555 1.45 LINK OE2 GLU A 272 ZN ZN A 503 1555 6555 2.46 LINK NE2 HIS A 285 ZN ZN A 501 1555 1555 2.59 LINK OE1 GLU A 294 ZN ZN A 502 1555 6555 2.24 LINK OE2 GLU A 294 ZN ZN A 502 1555 6555 2.41 LINK NE2 HIS A 310 ZN ZN A 502 1555 1555 1.96 LINK OE2 GLU A 345 ZN ZN A 503 1555 1555 2.43 LINK NE2 HIS A 435 ZN ZN A 502 1555 1555 1.93 LINK ZN ZN A 501 O HOH A 604 1555 1555 1.82 LINK ZN ZN A 502 O HOH A 601 1555 6554 1.86 CISPEP 1 TYR A 373 PRO A 374 0 -4.52 CRYST1 101.306 101.731 69.044 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009871 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009830 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014484 0.00000